| abstract |
Embodiments of the invention provide modulation of an immune response comprising modulating the interaction between a death-related protein kinase (DAPK) and a pathway of the Interferon Gene Stimulation Protein (STING). . According to some embodiments, the invention relates to a method of treating a patient with an inflammatory or autoimmune disease, or a cancer, or an associated adverse effect or symptom, by administering the an agent that modulates the interaction between a DAPK and the STING path. |